Long Term Experience With Abatacept in Routine Clinical Practice

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

NCT03419143 ·Status: COMPLETED

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

NCT00558506 ·Status: UNKNOWN ·Phase: PHASE2

Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia

NCT02778906 ·Status: COMPLETED ·Phase: PHASE3

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

NCT02632890 ·Status: COMPLETED

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

NCT05421442 ·Status: COMPLETED

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

NCT00989235 ·Status: COMPLETED ·Phase: PHASE3

Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)

NCT03492658 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb

NCT01439204 ·Status: COMPLETED ·Phase: PHASE1

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis

NCT01299961 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate

NCT00619905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

NCT06712628 ·Status: RECRUITING

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

NCT00195364 ·Status: COMPLETED

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

NCT01166620 ·Status: COMPLETED

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

NCT00767325 ·Status: COMPLETED ·Phase: PHASE3

Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker

NCT04106804 ·Status: UNKNOWN ·Phase: PHASE4

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice

NCT01692899 ·Status: COMPLETED

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment

NCT00902005 ·Status: COMPLETED

Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA

NCT02509026 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

NCT00421980 ·Status: COMPLETED ·Phase: PHASE3